Details for 2018842505
Up to date per 03.04.2026
Actions
Details for 2018842505
Granted/Registered
European Patent
28.10.2020 A
19.01.2022 B1
21.12.2017
US
201762609214 P
05.07.2018
US
201862694387 P
C07K 1/22 20060101AFI20190628BHEP
Owner
Genzyme Corporation50 Binney Street Cambridge, MA 02142US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
BEIGIE, Carl A.c/o Sanofi 55 Corporate Drive Mail Code: 55A-525 Bridgewater, New Jersey 08807US
Information about Fees